Clinical Trials

Clinical Trial Resources

1.Research Participants Needed for Studies on Glucose Metabolism and Diabetes

Male and Female individuals with Type 1 Diabetes

Ages 18-50 years, Participants will be compensated for their time.

Contact information:

Maia Mikeladze, MD, Vanessa Briscoe, PhD, NP,Sofio Dumbadze, MD, Maka Hedrington, MD

Email: DiabetesStudies@som.umaryland.edu or call 410-706-5643

2. Dexcom Study for people with Type 2 Diabetes Not on Insulin

The study is referred to as “Continuous Glucose Monitoring and Management in Type 2 Diabetes” also known as The COMMITED Study” and will assess if patients with Type 2 diabetes who have sub-optimal glycemic control using 2 or more multiple oral agents are able to make lifestyle changes resulting in improved glycemic control by use of real-time continuous glucose monitoring and targeted learning modules. https://clinicaltrials.gov/ct2/show/NCT03620357?term=Dexcom+g6+COMMITED&rank=1

3. Local CGM study

Welldoc is looking for individuals with diabetes, type 1 or type 2; injecting meal time insulin and using Dexcom or Libre CGM. Participants get a $150 gift card. The study takes 90 minutes or less and is held close to our office in Columbia. Please see below.

The study requires your on-site participation
in a 1 1/2 hour long session during which you
will be asked to perform specific tasks using a
mobile application on a smart phone and a
computer.To Qualify, You Should:
-Be 18 years of age or older
-Check your glucose using a blood glucose
meter or a Dexcom Continuous Glucose
Monitor or an Abbott Freestyle Libre CGM
-Take basal (long-acting) and bolus (short-acting)
insulin by syringe or insulin pen
-Currently use a smartphone and are
comfortable with the use of mobile apps and
desktop comp

To register for the study, call:
(888) 611 – 4794

4. Type 1 Diabetes study

An immunomodulation study geared towards individuals who have been diagnosed with Type 1 Diabetes Mellitus less than 150 days (at the time of randomization). See link below:

https://clinicaltrials.gov/ct2/show/NCT03751007?term=intrexon&rank=1

Alert Notice

Medicare G6 Coverage

Attention Medicare patients using Dexcom- as of Oct 8th, you will be able to use Dexcom G6 CGM! Dexcom G6 CGM is an improved version of Dexcom CGM. The improvements on the prior version include: 10 day sensor duration, no Tylenol interference with the accuracy of the readings, a much easier insertion that is virtually painless and can be done with one hand, and most importantly, no requirement for finger stick calibration.

Current Medicare patients on the Dexcom G5 CGM will be able to upgrade to the Dexcom G6 when their current G5 transmitter, which has to be replaced every 90 days, is going to expire. They will be sent a G6 transmitter and supplies. None of the G5 supplies will work with the G6 except newer Touchscreen receivers, which need to be upgraded. To assist people with this exciting transition, Dexcom representative Adrienne Augustino (443-253-2094) will be doing training and assistance with upgrading or replacing the receiver or phone app. Please note, if you have a T-Slim X2 pump, you will need to do training on the Basal IQ feature before downloading the T-Slim pump Basal IQ upgrade, which is required in order to use the Dexcom G6 with the T-Slim pump. That training can be arranged through T-Slim. The local representative for T-Slim is Tim Cooley (TCooley@tandemdiabetes.com mobile #(202) 841-4388 ).

To help our Medicare patients with this exciting transition, Adrienne Augustino (443-253-2094) will be in our office between noon and 4 pm on Fridays for the next several months. If you are interested, we will accept walk in’s but an appointment is preferred. The appointment should be made through Adrienne and not Maryland Endocrine, though the training will occur at our office. The training is free and involves no charge to you or your insurance.